Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss

Clinical trial NCT04701333 · COMPLETED

Trial details

NCT number: NCT04701333
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lactation Suppressed

Start date: 2021-04-01
Primary completion: 2022-06-24
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.